Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32025D0459

Commission Implementing Decision (EU) 2025/459 of 10 March 2025 repealing Implementing Decision (EU) 2024/2410 postponing the expiry date of the approval of dinotefuran for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

C/2025/1436

OJ L, 2025/459, 11.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/459/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document No longer in force, Date of end of validity: 31/03/2025

ELI: http://data.europa.eu/eli/dec_impl/2025/459/oj

European flag

Official Journal
of the European Union

EN

L series


2025/459

11.3.2025

COMMISSION IMPLEMENTING DECISION (EU) 2025/459

of 10 March 2025

repealing Implementing Decision (EU) 2024/2410 postponing the expiry date of the approval of dinotefuran for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(5) thereof,

After consulting the Standing Committee on Biocidal Products,

Whereas:

(1)

Dinotefuran was approved until 31 May 2022 as an active substance for use in biocidal products of product-type 18 by Commission Implementing Regulation (EU) 2015/416 (2), subject to the conditions set out in the Annex to that Regulation (‘the approval’).

(2)

On 11 November 2020, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of dinotefuran for use in biocidal products of product-type 18 (‘the application’). The application was evaluated by the competent authority of Belgium.

(3)

Pursuant to Commission Implementing Decision (EU) 2021/1286 (3), the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 was postponed to 30 November 2024, in order to allow sufficient time for the examination of the application. That expiry date was further postponed to 30 November 2025 by Commission Implementing Decision (EU) 2024/2410 (4).

(4)

Commission Implementing Regulation (EU) 2025/457 (5) renewed the approval of dinotefuran for use in biocidal products of product-type 18, subject to the conditions in the Annex to that Regulation, including the expiry date of approval. Therefore, it is appropriate to repeal Implementing Decision (EU) 2024/2410 postponing the initial expiry date of the approval of dinotefuran,

HAS ADOPTED THIS DECISION:

Article 1

Implementing Decision (EU) 2024/2410 is repealed.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 10 March 2025.

For the Commission

The President

Ursula VON DER LEYEN


(1)   OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.

(2)  Commission Implementing Regulation (EU) 2015/416 of 12 March 2015 approving dinotefuran as an active substance for use in biocidal products for product-type 18 (OJ L 68, 13.3.2015, p. 30, ELI: http://data.europa.eu/eli/reg_impl/2015/416/oj).

(3)  Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 (OJ L 279, 3.8.2021, p. 39, ELI: http://data.europa.eu/eli/dec_impl/2021/1286/oj).

(4)  Commission Implementing Decision (EU) 2024/2410 of 13 September 2024 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/2410, 16.9.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/2410/oj).

(5)  Commission Implementing Regulation (EU) 2025/457 of 10 March 2025 renewing the approval of dinotefuran as an active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/457, 11.3.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/457/oj).


ELI: http://data.europa.eu/eli/dec_impl/2025/459/oj

ISSN 1977-0677 (electronic edition)


Top